Head-to-head · Cost-Efficiency Index
Maves vs KIN Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Maves
Shoppers drawn to aggressive low intro pricing on semaglutide who will confirm the exact charge before checkout.
Visit MavesKIN Health
Shoppers who want a published month-to-month price for compounded semaglutide or tirzepatide with no membership fee and named pharmacies.
Visit KIN HealthThe verdict
Maves and KIN Health tie on the Cost-Efficiency Index at 76/100, so neither wins outright on the numbers, so choose on fit. Maves: Shoppers drawn to aggressive low intro pricing on semaglutide who will confirm the exact charge before checkout. KIN Health: Shoppers who want a published month-to-month price for compounded semaglutide or tirzepatide with no membership fee and named pharmacies.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Maves.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Maves | KIN Health |
|---|---|---|
| Cost-Efficiency Index | 76/100 | 76/100 |
| Semaglutide / mo | $89/moStarting dose, compounded | $169/moCompounded, month to month, same price at every dose |
| Tirzepatide / mo | Not disclosed | $199/moCompounded, month to month |
| Semaglutide / yr (modeled) | $1,068 | $2,028 |
| Tirzepatide / yr (modeled) | — | $2,388 |
| Coverage | All 50 states | 44 states + DC |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #63 | #67 |
Maves
76/100Where the value is
- LegitScript badge displayed on the site
- Publishes the FDA compounded-medication disclaimer
- Low advertised semaglutide entry price ($89-99/mo range)
The tradeoffs
- The homepage shows two different numbers for the same starting semaglutide tier ($89/month vs $99 first month), so confirm the ongoing price before you pay
- Tirzepatide is listed as an offering, but no tirzepatide price is published on the site
KIN Health
76/100Where the value is
- Semaglutide is $169 a month and tirzepatide $199, month to month, with the medication, provider care, messaging and shipping in the price
- Semaglutide is the same price at every dose
- Names its pharmacies (Drug Crafters, Boothwyn and Strive) and publishes a directory of its prescribing physicians with license numbers
The tradeoffs
- The weight-loss page promises one flat price at every dose, but the terms say your tirzepatide price may change as your dose goes up
- The program page says no subscriptions and no auto-renew, while the terms describe GLP-1 refills charged automatically each cycle until you turn them off
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.